BioClé deploys bacterial vesicles to boost bioactive bioavailability

· Agriculture & Food

BioClé is tackling the bioavailability challenge for bioactives with a novel delivery technology built on tiny bacterial extracellular vesicles. These vesicles have a natural affinity for intestinal cells and can be loaded with bioactives, potentially improving how much of an ingredient the body actually absorbs. Poor bioavailability has long limited the effectiveness of many functional ingredients in food and supplements, forcing higher doses or limiting formulations. By using vesicles that target intestinal cells, BioClé aims to make delivery more efficient. The company joins a field of startups developing delivery systems meant to make functional ingredients more effective at lower doses.

Why it matters：Bioavailability limits what functional ingredients can deliver, and better delivery tech could widen the range of bioactives viable in food and supplements.

Key points

  • The technology uses tiny bacterial extracellular vesicles.
  • The vesicles have a natural affinity for intestinal cells and can be loaded with bioactives.

Sources (original reporting)

More stories from this day